NO924704L - Medikamenter for behandling av betennelsestilstander og for analgesi - Google Patents

Medikamenter for behandling av betennelsestilstander og for analgesi

Info

Publication number
NO924704L
NO924704L NO92924704A NO924704A NO924704L NO 924704 L NO924704 L NO 924704L NO 92924704 A NO92924704 A NO 92924704A NO 924704 A NO924704 A NO 924704A NO 924704 L NO924704 L NO 924704L
Authority
NO
Norway
Prior art keywords
treatment
medicinals
analgesia
conditions
treatment conditions
Prior art date
Application number
NO92924704A
Other languages
English (en)
Other versions
NO303670B1 (no
NO924704D0 (no
Inventor
Roger Stables
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919126027A external-priority patent/GB9126027D0/en
Priority claimed from GB929206083A external-priority patent/GB9206083D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO924704D0 publication Critical patent/NO924704D0/no
Publication of NO924704L publication Critical patent/NO924704L/no
Publication of NO303670B1 publication Critical patent/NO303670B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO924704A 1991-12-06 1992-12-04 Farmasøytisk produkt inneholdende ranitidin vismutcitrat og et ikke-steroid, anti-inflammatorisk legemiddel samt anvendelse av disse NO303670B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919126027A GB9126027D0 (en) 1991-12-06 1991-12-06 Medicaments
GB929206083A GB9206083D0 (en) 1992-03-20 1992-03-20 Medicaments

Publications (3)

Publication Number Publication Date
NO924704D0 NO924704D0 (no) 1992-12-04
NO924704L true NO924704L (no) 1993-06-07
NO303670B1 NO303670B1 (no) 1998-08-17

Family

ID=26299971

Family Applications (1)

Application Number Title Priority Date Filing Date
NO924704A NO303670B1 (no) 1991-12-06 1992-12-04 Farmasøytisk produkt inneholdende ranitidin vismutcitrat og et ikke-steroid, anti-inflammatorisk legemiddel samt anvendelse av disse

Country Status (26)

Country Link
US (1) US5466436A (no)
EP (1) EP0550083B1 (no)
JP (1) JPH05246853A (no)
KR (1) KR930009605A (no)
AP (1) AP324A (no)
AT (1) AT401468B (no)
AU (1) AU664574B2 (no)
BE (1) BE1007268A3 (no)
CA (1) CA2084568A1 (no)
CH (1) CH685537A5 (no)
CZ (1) CZ358092A3 (no)
DE (1) DE69228738D1 (no)
DK (1) DK0550083T3 (no)
ES (1) ES2130152T3 (no)
FR (1) FR2684554B1 (no)
GB (1) GB2262036B (no)
GR (1) GR3030426T3 (no)
IE (1) IE922866A1 (no)
IL (1) IL103978A (no)
IT (1) IT1256697B (no)
LU (1) LU88196A1 (no)
MX (1) MX9207008A (no)
MY (1) MY108146A (no)
NO (1) NO303670B1 (no)
NZ (1) NZ245365A (no)
PH (1) PH31380A (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501560D0 (en) 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
JPH10512877A (ja) * 1995-01-26 1998-12-08 ニコムド イメージング エイ／エス ビスマス化合物
TR199901101T2 (xx) * 1996-11-22 1999-07-21 The Procter & Gamble Company Gastroenstentinal hastal�klar�n tedavisine y�nelik bizmut ve nsaid i�eren bile�imler.
EP0941101A1 (en) * 1996-11-22 1999-09-15 The Procter & Gamble Company Compositions for the treatment of gastrointestinal disorders containing bismuth, and nsaid and one or more antimicrobials
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
SE0000774D0 (sv) 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
JP2004520422A (ja) * 2001-03-08 2004-07-08 アストラゼネカ・アクチエボラーグ 新しい用途
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
EP1411900B2 (en) 2001-06-01 2013-12-04 Pozen, Inc. PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs
SE0102993D0 (sv) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
US8067451B2 (en) * 2006-07-18 2011-11-29 Horizon Pharma Usa, Inc. Methods and medicaments for administration of ibuprofen
CA2615496C (en) * 2005-07-18 2014-11-18 Horizon Therapeutics, Inc. Medicaments containing famotidine and ibuprofen and administration of same
US20080021078A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Methods and medicaments for administration of ibuprofen
US20080020040A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Unit dose form for administration of ibuprofen
US8067033B2 (en) * 2007-11-30 2011-11-29 Horizon Pharma Usa, Inc. Stable compositions of famotidine and ibuprofen
WO2008027963A2 (en) * 2006-08-31 2008-03-06 Horizon Therapeutics, Inc. Nsaid dose unit formulations with h2-receptor antagonists and methods of use
EA201100313A1 (ru) 2008-09-09 2011-10-31 Астразенека Аб Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом
CA2764963C (en) 2009-06-25 2016-11-01 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
BR112014016085A8 (pt) 2011-12-28 2017-07-04 Pozen Inc composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico
CN110893233A (zh) * 2019-12-19 2020-03-20 川北医学院附属医院 一种鸢尾素在制备抗炎药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464679A (en) * 1981-07-06 1984-08-07 Rca Corporation Method and apparatus for operating a microprocessor in synchronism with a video signal
CY1398A (en) * 1981-09-04 1987-12-18 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
CA1211374A (en) * 1982-05-14 1986-09-16 Eszter Cholnoky Pharmaceutical compositions containing more active ingredients
US4757060A (en) * 1986-03-04 1988-07-12 Bristol-Myers Company Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers
GB8625325D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
EP0282132B1 (en) * 1987-03-09 1992-09-30 The Procter & Gamble Company Compositions and their use for treating gastrointestinal disorders
CH679582A5 (no) * 1988-07-18 1992-03-13 Glaxo Group Ltd
NZ235877A (en) * 1989-11-02 1992-09-25 Mcneil Ppc Inc Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions

Also Published As

Publication number Publication date
CZ358092A3 (en) 1993-10-13
GR3030426T3 (en) 1999-09-30
GB9225174D0 (en) 1993-01-20
ATA240692A (de) 1996-02-15
NO303670B1 (no) 1998-08-17
DE69228738D1 (de) 1999-04-29
KR930009605A (ko) 1993-06-21
AT401468B (de) 1996-09-25
CA2084568A1 (en) 1993-06-07
IE922866A1 (en) 1993-06-16
LU88196A1 (fr) 1993-08-17
US5466436A (en) 1995-11-14
NZ245365A (en) 1997-06-24
FR2684554B1 (fr) 1995-09-08
EP0550083A1 (en) 1993-07-07
MX9207008A (es) 1993-06-01
BE1007268A3 (fr) 1995-05-09
MY108146A (en) 1996-08-30
JPH05246853A (ja) 1993-09-24
IL103978A0 (en) 1993-05-13
AU2986392A (en) 1993-06-10
CH685537A5 (fr) 1995-08-15
AU664574B2 (en) 1995-11-23
FR2684554A1 (fr) 1993-06-11
GB2262036B (en) 1996-01-03
AP9200453A0 (en) 1993-01-31
ITRM920869A0 (it) 1992-12-04
NO924704D0 (no) 1992-12-04
GB2262036A (en) 1993-06-09
DK0550083T3 (da) 1999-10-11
ES2130152T3 (es) 1999-07-01
ITRM920869A1 (it) 1994-06-04
AP324A (en) 1994-03-07
PH31380A (en) 1998-10-29
EP0550083B1 (en) 1999-03-24
IT1256697B (it) 1995-12-12
IL103978A (en) 1998-06-15

Similar Documents

Publication Publication Date Title
NO924704D0 (no) Medikamenter for behandling av betennelsestilstander og for analgesi
NO934547D0 (no) Oral behandling av Helicobacter-in-feksjon
NO944164D0 (no) Fremgangsmåte for fremstilling og anvendelse av en HCl-adsorbent
NO174492C (no) Fremgangsmåte og installasjon for behandling av væske
NO920780L (no) Fremgangsmaate og anordning for behandling av epilepsi
FI935135A0 (fi) Foerfarande foer rening av TiO2-malm
NO921485L (no) Fremgangsmaate og anlegg for avhendelse av borkaks
FI942696L (fi) Fluorihiilivetyjen valmistus alfa-fluorieettereistä ja alfa-fluorieetterit
NO921589D0 (no) Fremgangsmaate for fremstilling av lavere polyoler og blandinger derav
NO971900D0 (no) Blandinger og behandling av multippel sklerose
NO941163D0 (no) Behandling av kjött
NO172838C (no) Fremgangsmaate og anlegg for behandling av avfallsprodukter
NO940027D0 (no) Fremgangsmaate for fremstilling av derivater av _fenylisoserin og derivatenes anvendelse
IS1748B (is) Fóður og aðferð við framleiðslu þess
NO961226L (no) Blandinger for forebyggelse og behandling av viralinduserte tumorer
NO932129D0 (no) Fremgangsmaate for fremstilling og anvendelse av nye tienotiazinderivater
NO940190D0 (no) Anvendelse av x-ketoglutarat
NO961808D0 (no) Konstruksjon og produksjon av vaksine
NO952261D0 (no) Antacidiumforbindelser og fremgangsmåte for fremstilling derav
DE69208096D1 (de) Herstellung von dialkyltellur und dialkylselen
NO942531D0 (no) Fremgangsmåte for fremstilling av 3-acylöstratriener og acylbenzener
NO924390D0 (no) Fremgangsmaate og system for fremskaffelse av volumgjengivelse
NO921720D0 (no) Behandling av brystkjertelbetennelse
FI951494A0 (fi) Jyvien käsittely laajentimella
DK394388D0 (da) 5-pyrimidincarboxamider og behandling af leukaemi dermed